Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2009 Jun;11(6):339–344. doi: 10.1089/dia.2008.0107

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright 2009, Mary Ann Liebert, Inc.

PMC Copyright notice

FIG. 1. — ADRR distribution by each study visit is shown for exenatide and insulin glargine over the course of study. Overall, ADRR was lower for exenatide-treated patients (P = 0.001). A 2 × 6 analysis of variance of ADRR per study visit after the first visit shows that variability is reduced shortly after the initiation of treatment in both groups (F = 112.5, P < 0.001), and reduction of variability is slightly more pronounced for exenatide-treated patients compared with glargine-treated patients (treatment × visit effect, F = 7.1, P < 0.0001). Data are mean ± SE values.